Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

18FMNI 958

Drug Profile

18FMNI 958

Alternative Names: [18F]-MNI-958; APN-0000455; PM-PBB3

Latest Information Update: 08 Jun 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Molecular NeuroImaging
  • Class Diagnostic agents; Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Positron-emission tomography enhancers; Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I Alzheimer's disease; Progressive supranuclear palsy

Most Recent Events

  • 12 Mar 2018 Phase-I clinical trials in Alzheimer's disease (Diagnosis) in USA (Injection) (NCT03545789)
  • 12 Mar 2018 Phase-I clinical trials in Progressive supranuclear palsy (Diagnosis) in USA (Injection) (NCT03545789)
  • 14 Nov 2017 Phase-I clinical trials in Healthy volunteers in USA (Injection) (NCT03472313)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top